A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma (clinicaltrials.gov) - Sep 12, 2026 - P1 | N=22 | Active, not recruiting | Sponsor: Memorial Sloan Kettering Cancer Center | Trial completion date: Nov 2026 ➔ Nov 2027 | Trial primary completion date: Nov 2026 ➔ Nov 2027
Trial completion date • Trial primary completion date • Malignant Pleural Mesothelioma • Mesothelioma • Oncology • Pleural Mesothelioma • Solid Tumor
|